Migyeom Kim is Lead Scientist of Cellular Engineering Group at Samsung Biologics. She has over ten years of experience in drug development within the biologics industry. She joined Samsung Biologics in 2021, and has led multiple CLD projects for a wide range of global clients. Migyeom also played a pivotal role in the creation and optimization of multiple internal platform technologies. She holds a Ph.D. in Biotechnology from the Korea Advanced Instittue of Science and Technology (KAIST).
